Skip to main content
. 2018 Jul 31;34:61–75. doi: 10.1016/j.ebiom.2018.07.013

Table 1.

Characteristics of the patients included in the study.

Item CML-CP (n = 30) CML-AP (n = 15) CML-BP (n = 15)
Age (years), median (range) 41.4(9–65) 49.1(13–69) 51.9(20–69)
Male/female, (n/n) 20/10 9/6 10/5
WBCs × 109/median (range) 221.4(30.2–517) 263.5(47.4–396) 69.5(27.4–224)
Hemoglobin level (g/l) 94(76–120) 75(61–105) 62.4(52–79)
Platelet count,109/median (range) 518(99–809) 305(52–725) 35.5(19–71)

AP, accelerated phase; BP, blast phase; CML, chronic myeloid leukemia; CP, chronic phase; WBC, white blood cells.